Protective effect of thymoquinone in sepsis
AssigneeKing Saud University
InventorsKhalid M Alkharfy, Nasser M. Al-Daghri, Omar S. Al-Attas, Majed S. Alokail
Life of this patent
Estimating the term…
Abstract
The present invention refers to thymoquinone, a main constituent of the volatile oil of Nigella sativa, and its protective effect against sepsis syndrome morbidity, mortality and associated organ dysfunctions. In particular, the present invention refers to thymoquinone for use in the prevention and/or treatment of sepsis syndrome. The present invention further refers to a pharmaceutical composition and a kit.
Claims9
A method for treating sepsis in a human being in need thereof comprising:
- systemically administering to the human being an effective amount of thymoquinone for
- a period of time sufficient to provide a protective effect against mortality in sepsis.
A method for preventive treatment of a human being against sepsis prior to or upon admission to an intensive care unit of a hospital, said method comprising:
- systemically administering to the human being an effective amount of thymoquinone for a period of time
- sufficient to provide a protective effect against the occurrence of sepsis.
Dependencies are inferred from the claim text.